secwatch.observer — SEC 8-K summary
======================================

Issuer:     Autolus Therapeutics plc (AUTL)
CIK:        0001730463
Form:       8-K
Filed at:   2025-04-03T23:59:59+00:00
Accession:  0001193125-25-072356
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Autolus Therapeutics VP Finance resigns; CFO Dolski appointed PAO
-----------------------------------------------------------------

- Andrew Mercieca resigned as VP Finance & PAO on Feb 24, 2025, effective August 2025; not due to any disagreement.
- CFO Rob Dolski appointed principal accounting officer effective April 3, 2025, in addition to his CFO role.
- No additional compensation for Dolski for the added PAO duties; no family or transaction disclosures.
- Mercieca's resignation follows a statutory three-month minimum notice period under UK law.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1730463/000119312525072356/0001193125-25-072356-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1730463/000119312525072356/d945856d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-072356

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer